Download PDF
CC BY-NC-ND 4.0 · Geburtshilfe Frauenheilkd
DOI: 10.1055/a-2436-1699
GebFra Science
Original Article

Indocyanine Green Marking of Axillary Sentinel Lymph Nodes in Early Breast Cancer

Article in several languages: English | deutsch
Steffi Hartmann
1   Universitätsfrauenklinik und Poliklinik, Klinikum Südstadt, Rostock, Germany
,
Meri-Liis Plonus
1   Universitätsfrauenklinik und Poliklinik, Klinikum Südstadt, Rostock, Germany
,
Gesche Schultek
1   Universitätsfrauenklinik und Poliklinik, Klinikum Südstadt, Rostock, Germany
2   Diagnostische und interventionelle Radiologie, Klinikum Südstadt, Rostock, Germany (Ringgold ID: RIN219474)
,
Johannes Stubert
1   Universitätsfrauenklinik und Poliklinik, Klinikum Südstadt, Rostock, Germany
,
Bernd Gerber
1   Universitätsfrauenklinik und Poliklinik, Klinikum Südstadt, Rostock, Germany
,
Toralf Reimer
1   Universitätsfrauenklinik und Poliklinik, Klinikum Südstadt, Rostock, Germany
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Introduction

Axillary sentinel lymph node excision (SLNE) in breast cancer patients with clinically node-negative disease may be carried out using different tracers. The standard tracer is technetium colloid (99mTc). Indocyanine green (ICG) can be used as an alternative. This study aimed to evaluate the clinical usefulness of this fluorescent dye in a standardized setting.

Material and Methods

A prospective, single-center cohort study carried out at the University Gynecological Hospital of Rostock from September 2023 to May 2024 carried out sentinel lymph node marking using only ICG in patients with breast malignancies. The ICG injection was administered immediately after the induction of anesthesia. Detection of the sentinel lymph node (SLN) was done using a laparoscopy system suitable for ICG. The aim was to determine the detection rate (DR) for SLNs marked exclusively using ICG and to record any complications. The costs of using ICG to mark SLNs were compared with those for 99mTc marking.

Results

During the study period, contraindications against marking with ICG were ascertained for five (3.8%) of 132 patients with planned SLNE. A total of 100 SLNEs were carried out after ICG marking in patients who met the inclusion criteria in the context of the study. A median of two SLNs were resected. The detection rate (DR) for SLNs was 98.0%. SLNs were identified in all obese patients. No serious systemic side effects occurred following ICG injection. Transient skin discoloration in the area around the injection site were observed in eight patients. The direct cost of ICG marking was 62.73 Euros, which was 170.36 Euros lower than the cost of 99mTc marking.

Conclusion

The detection rate of axillary SLNs marked using ICG is high and the method is cost-effective, has few side effects and can also be used in obese patients. Contraindications against the administration of ICG are rare. Marking with ICG is a good alternative to the 99mTc method and offers advantages in terms of costs, logistics, no exposure to radiation, and patient comfort.

Keywords

breast cancer - sentinel lymph node - indocyanine green - fluorescence - sentinel lymph node excision


Publication History

Received: 03 September 2024

Accepted after revision: 06 October 2024

Article published online:
12 November 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany